| Toripalimab studied in …STUDIED_INderived200 of 335show all (up to 200) |
|---|
| → studied in | NCT07559929Phase 1/Phase 2 · recruiting A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer. · 335 trials list this drug (191 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06088004Phase 1/Phase 2 · recruiting Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836049Phase 2 · not yet recruiting PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCC · 335 trials list this drug (191 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835035Phase 1 · recruiting Rimegepant Plus Toripalimab in Advanced Urothelial Carcinoma After Failure of Standard Therapy · 335 trials list this drug (191 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04387084Phase 1 · active not recruiting Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy · 335 trials list this drug (191 active) | — | — | Malignant Skin Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07562841Phase 1 · recruiting Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy · 335 trials list this drug (191 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823270Phase 2 · not yet recruiting Neoadjuvant Sacituzumab Tirumotecan Plus Toripalimab in Locally Advanced Esophageal Squamous Cell Carcinoma · 335 trials list this drug (191 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823348Phase 3 · not yet recruiting JS207 Plus JS007 Versus Toripalimab Plus Bevacizumab as First-Line Treatment for Advanced Liver Cancer · 335 trials list this drug (191 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819578Phase 2 · not yet recruiting Toripalimab Plus Sacituzumab Tirumotecan as Neoadjuvant Therapy for Resectable NSCLC · 335 trials list this drug (191 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07816770Phase 2 · not yet recruiting MANTIS-RCC: Toripalimab-Axitinib Induction in TLS-Positive Advanced Non-Clear Cell and Renal Medullary Carcinomas · 335 trials list this drug (191 active) | — | — | Non-Clear Cell Renal Cell Carcinoma,Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07817095Phase 2 · not yet recruiting SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic Sarcoma · 335 trials list this drug (191 active) | — | — | Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05715931Phase 2 · active not recruiting Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma · 335 trials list this drug (191 active) | — | — | Gastric Adenocarcinoma,Gastroesophageal Junction Adenocarcinoma,HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07189793Phase 2 · not yet recruiting Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study · 335 trials list this drug (191 active) | — | — | Transitional Cell Carcinoma,Bladder Neoplasm,Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808216Phase 2 · not yet recruiting Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05518045Phase 1/Phase 2 · active not recruiting A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06940180Phase 2 · recruiting Toripalimab With Chemotherapy for Sinus Cancer · 335 trials list this drug (191 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Sinonasal Neoplasm,Paranasal Sinus Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796126Phase 2 · not yet recruiting Sequential Toripalimab and Paclitaxel in Patients With Head and Neck Squamous Cell Cancer (HNSCC) and Poor Performance Status · 335 trials list this drug (191 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07776717Phase 2 · not yet recruiting TACTIC-RCC: Toripalimab Plus Axitinib Induction With Selective Deferred Cytoreductive Nephrectomy in TLS-Positive Advanced Clear Cell Renal Cell Carcinoma · 335 trials list this drug (191 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06914440Phase 2 · recruiting Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer · 335 trials list this drug (191 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05635643Phase 1 · active not recruiting Study of CHS-114 in Participants With Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06139211Phase 1/Phase 2 · completed A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07277322Phase 1/Phase 2 · recruiting Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases · 335 trials list this drug (191 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04354662Phase 2 · completed Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer · 335 trials list this drug (191 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07757022not yet recruiting AI-Driven Digital Twin and Drug Simulation for Esophageal Cancer · 335 trials list this drug (191 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03859128Phase 2/Phase 3 · active not recruiting Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection · 335 trials list this drug (191 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07756008Phase 2/Phase 3 · not yet recruiting Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder Cancer · 335 trials list this drug (191 active) | — | — | Bladder Neoplasm,Bladder Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05502393Phase 1 · active not recruiting A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03924050Phase 3 · completed Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI · 335 trials list this drug (191 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07677475Phase 2 · not yet recruiting MRG003 Plus Toripalimab Versus Toripalimab as Neoadjuvant Therapy for PD-L1-Positive, Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma · 335 trials list this drug (191 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04856631Phase 1/Phase 2 · completed A Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Cancer · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07611825Phase 2 · recruiting Gut Microbiota Modulation for Immunotherapy Resensitization in Advanced Renal Cell Carcinoma · 335 trials list this drug (191 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07680582early Phase 1 · recruiting An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06457503Phase 4 · recruiting A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06095583Phase 3 · recruiting Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC) · 335 trials list this drug (191 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04918186Phase 2 · recruiting Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer · 335 trials list this drug (191 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07717242Phase 2 · recruiting Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer · 335 trials list this drug (191 active) | — | — | Bladder Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04374877Phase 1 · completed Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm,Hepatocellular Carcinoma,Lung Non-Small Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06657144Phase 1 · recruiting A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06679985Phase 2 · active not recruiting A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma · 335 trials list this drug (191 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06964906Phase 2 · recruiting Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer · 335 trials list this drug (191 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07214987Phase 2 · recruiting PDT For Induction Therapy For Head And Neck Cancer · 335 trials list this drug (191 active) | — | — | Malignant Head and Neck Neoplasm,Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05813626Phase 2 · active not recruiting Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04568304Phase 3 · withdrawn A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma · 335 trials list this drug (191 active) | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05751486Phase 1 · completed A Clinical Study to Evaluate the Safety and Tolerability of JS001sc in Advanced Nasopharyngeal Carcinoma · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07685535Phase 2 · not yet recruiting HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma · 335 trials list this drug (191 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07508761Phase 1/Phase 2 · recruiting IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07669220Phase 2 · recruiting A Multicenter, Randomized Controlled Phase II Study of Short-Course Radiotherapy Followed by Sequential PD-1 Inhibitor and FOLFOX Chemotherapy Versus Long-Course Chemoradiotherapy for High-Risk Locally Advanced pMMR/MSS Lower Rectal Adenocarcinoma (STAR Trial) · 335 trials list this drug (191 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592599Phase 2 · recruiting Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC) · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07657325recruiting Study on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Renal Carcinoma · 335 trials list this drug (191 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07646080Phase 2 · not yet recruiting Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans · 335 trials list this drug (191 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07647289Phase 2 · recruiting EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC · 335 trials list this drug (191 active) | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07358689Phase 2 · not yet recruiting Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung Cancer · 335 trials list this drug (191 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07630363Phase 1/Phase 2 · not yet recruiting PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC · 335 trials list this drug (191 active) | — | — | Renal Cell Carcinoma,Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07480733Phase 2 · recruiting Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors · 335 trials list this drug (191 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07608224Phase 2/Phase 3 · not yet recruiting HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable HER2-Expressing MIBC · 335 trials list this drug (191 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07325539Phase 2 · recruiting LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06378177Phase 2 · active not recruiting A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC) · 335 trials list this drug (191 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07099430Phase 1/Phase 2 · recruiting A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma · 335 trials list this drug (191 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07309276Phase 2 · recruiting A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer · 335 trials list this drug (191 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05173142Phase 1/Phase 2 · completed A Phase Ib/II Clinical Study Evaluating HMPL-453 Tartrate as Monotherapy and in Combination With Chemotherapy or Toripalimab in Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06618014Phase 2 · active not recruiting Neoadjuvant Toripalimab Plus Docetaxel and Carboplatin in Patients With Localized TNBC (NeoTOP) · 335 trials list this drug (191 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04322006Phase 1/Phase 2 · completed A Phase I/II Study of TJ004309 for Advanced Solid Tumor · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04640545Phase 1 · completed A Study to Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma · 335 trials list this drug (191 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06437977Phase 3 · recruiting Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) · 335 trials list this drug (191 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05340491Phase 3 · recruiting Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06323239Phase 2 · recruiting SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07571551Phase 2 · recruiting Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma · 335 trials list this drug (191 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06732258Phase 1 · withdrawn Low-dose Radiotherapy Combined With Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC · 335 trials list this drug (191 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07555860Phase 2 · not yet recruiting Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07550842Phase 1 · not yet recruiting A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer · 335 trials list this drug (191 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03810339Phase 2 · recruiting Toripalimab（JS001） as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07209189Phase 2 · recruiting Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN) · 335 trials list this drug (191 active) | — | — | Malignant Head and Neck Neoplasm,Squamous Cell Carcinoma,Malignant Laryngeal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07484724Phase 2 · recruiting A Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma · 335 trials list this drug (191 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07540390Phase 3 · not yet recruiting GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC. · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07177794Phase 3 · recruiting Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC · 335 trials list this drug (191 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07378306Phase 2 · recruiting FMD and Neoadjuvant Chemo-immunotherapy in TNBC · 335 trials list this drug (191 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07540533Phase 2 · recruiting A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer · 335 trials list this drug (191 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04085276Phase 3 · completed Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment · 335 trials list this drug (191 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07423078Phase 2 · recruiting Window of Opportunity in Preserving Laryngeal Function Trial · 335 trials list this drug (191 active) | — | — | Head and Neck Squamous Cell Carcinoma,Laryngeal Squamous Cell Carcinoma,Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07500831NA · not yet recruiting Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma · 335 trials list this drug (191 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07320963Phase 1/Phase 2 · not yet recruiting Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma. · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07481058Phase 2 · recruiting KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer · 335 trials list this drug (191 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07474064Phase 2 · not yet recruiting Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05479045Phase 2 · not yet recruiting A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients · 335 trials list this drug (191 active) | — | — | Ovarian Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07469956Phase 2 · not yet recruiting Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer · 335 trials list this drug (191 active) | — | — | Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05798845Phase 2 · recruiting The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer · 335 trials list this drug (191 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07457359Phase 2 · recruiting Neoadjuvant Toripalimab Plus SBRT for Chemo-Resistant Triple-Negative Breast Cancer · 335 trials list this drug (191 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06114940Phase 2 · terminated Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO) · 335 trials list this drug (191 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06208826Phase 2 · recruiting A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy · 335 trials list this drug (191 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05888402Phase 2 · active not recruiting Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07281716Phase 1/Phase 2 · recruiting Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC · 335 trials list this drug (191 active) | — | — | Microsatellite Stable Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07412171Phase 2 · not yet recruiting NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC · 335 trials list this drug (191 active) | — | — | Renal Pelvis and Ureter Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07410234Phase 2 · not yet recruiting Phase II Exploratory Study of Toripalimab Combined With SBRT in HER2-Negative Breast Cancer Patients With Insensitivity to Neoadjuvant Chemotherapy · 335 trials list this drug (191 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07281976Phase 1/Phase 2 · recruiting A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer · 335 trials list this drug (191 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07290621Phase 2 · recruiting Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer · 335 trials list this drug (191 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07392736Phase 1/Phase 2 · recruiting A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors. · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07388836Phase 2 · not yet recruiting Timing Optimization of Immunotherapy During Neoadjuvant Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04418648Phase 2 · terminated Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06771622Phase 1/Phase 2 · active not recruiting Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06984588Phase 2/Phase 3 · active not recruiting A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer · 335 trials list this drug (191 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07376499Phase 2 · not yet recruiting Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction · 335 trials list this drug (191 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07371897Phase 3 · not yet recruiting Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial · 335 trials list this drug (191 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07353723Phase 2 · recruiting Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07340515Phase 3 · recruiting Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284488Phase 1/Phase 2 · terminated Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06283134Phase 1 · not yet recruiting A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer · 335 trials list this drug (191 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04553939Phase 2 · completed Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer · 335 trials list this drug (191 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06416696Phase 2 · active not recruiting Toripalimab for High-risk Locally Advanced Cervical Cancer · 335 trials list this drug (191 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07314723Phase 2 · recruiting 9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer · 335 trials list this drug (191 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07308379not yet recruiting Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer · 335 trials list this drug (191 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06584435Phase 2 · active not recruiting A Study of Toripalimab in Adjuvant Therapy After Resection of High-risk Renal Cancer · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06293690Phase 2 · active not recruiting Toripalimab Combined With SBRT for NSCLC · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07111832Phase 3 · recruiting A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07272291Phase 2 · not yet recruiting A Phase II Study of Toripalimab Plus Chemotherapy and Low-Dose Radiotherapy for Neoadjuvant Therapy-Refractory Esophageal Squamous Cell Carcinoma · 335 trials list this drug (191 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05427396Phase 1 · terminated A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06735131Phase 2 · recruiting The Optimal Radioimmunotherapy Combinations for Advanced TNBC · 335 trials list this drug (191 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05664971Phase 1/Phase 2 · completed JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer · 335 trials list this drug (191 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07256964Phase 2 · not yet recruiting Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07258979Phase 1/Phase 2 · recruiting A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma. · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05975307Phase 2 · active not recruiting Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation · 335 trials list this drug (191 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07154069Phase 3 · recruiting Adaptive Immunotherapy for Nasopharyngeal Carcinoma · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07244874Phase 2 · not yet recruiting Sac-TMT Combined With Toripalimab for First-line Treatment of PD-L1 Positive a/mTNBC · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07245901Phase 1/Phase 2 · not yet recruiting Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07246330Phase 3 · not yet recruiting Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study · 335 trials list this drug (191 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05386888Phase 2 · completed A Trial of GFH018 and Toripalimab in Combination With Concurrent Chemoradiotherapy in Stage III NSCLC Chemoradiotherapy in Stage III NSCLC · 335 trials list this drug (191 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06178159Phase 2 · recruiting DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer · 335 trials list this drug (191 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05980481Phase 2/Phase 3 · active not recruiting A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer · 335 trials list this drug (191 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06623136Phase 2 · recruiting A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer · 335 trials list this drug (191 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07140679Phase 2 · recruiting Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer · 335 trials list this drug (191 active) | — | — | Colon Carcinoma,Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05934331Phase 2 · recruiting A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06868199Phase 1/Phase 2 · recruiting A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07040644Phase 2 · not yet recruiting A Study of Sacituzumab Govitecan Plus Toripalimab Versus Toripalimab Plus Nab-Paclitaxel in PD-L1 Positive Advanced TNBC · 335 trials list this drug (191 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07159217Phase 2 · not yet recruiting Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer · 335 trials list this drug (191 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06127303Phase 2 · recruiting Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC · 335 trials list this drug (191 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07136519Phase 2 · not yet recruiting Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06323382recruiting Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma · 335 trials list this drug (191 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06371274NA · recruiting A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC. · 335 trials list this drug (191 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07039656Phase 2 · recruiting Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Non-small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07097948Phase 2 · not yet recruiting Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Resection of Lung Cancer: A Single-Center, Randomized Controlled Clinical Study Protocol Number: LungMate-033 · 335 trials list this drug (191 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07092696Phase 2 · recruiting Induction Immunotherapy Combined With Chemotherapy Followed by Concurrent Chemoradiotherap and Immunotherapy for Cervical Cancer · 335 trials list this drug (191 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06208410Phase 1/Phase 2 · recruiting A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03829969Phase 3 · completed Toripalimab or Placebo With Paclitaxel and Cisplatin in Esophageal Squamous Cell Carcinoma · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05173246Phase 2 · recruiting JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma · 335 trials list this drug (191 active) | — | — | Esophageal Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05147844Phase 2 · recruiting Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07004244Phase 1 · recruiting Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies · 335 trials list this drug (191 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04991506Phase 1 · completed A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Neoplasm,Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05102006Phase 1/Phase 2 · completed A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant Tumors · 335 trials list this drug (191 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06987123Phase 2 · not yet recruiting TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06577532early Phase 1 · recruiting Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors · 335 trials list this drug (191 active) | — | — | Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06912711Phase 2 · recruiting TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04914286Phase 1/Phase 2 · completed A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05757492Phase 1 · terminated Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm,Hepatocellular Carcinoma,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05167071Phase 1 · active not recruiting HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study · 335 trials list this drug (191 active) | — | — | Solid Neoplasm,Neuroendocrine Tumor,Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05342194Phase 3 · recruiting Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study · 335 trials list this drug (191 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06843889Phase 2 · recruiting A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma · 335 trials list this drug (191 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06919848Phase 2 · not yet recruiting Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06) · 335 trials list this drug (191 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04517214Phase 2 · active not recruiting Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06903871Phase 2 · not yet recruiting Toripalimab Adjuvant Therapy in Subjects With Resected Esophageal Squamous Cell Carcinoma Who Achieved Pathological Complete Response (pCR) · 335 trials list this drug (191 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06904573Phase 2 · recruiting Probiotics in Advanced Urothelial Carcinoma · 335 trials list this drug (191 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06823427Phase 2 · recruiting 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma · 335 trials list this drug (191 active) | — | — | Urothelial Carcinoma,Renal Pelvis and Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06889649Phase 2 · recruiting SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04365036Phase 3 · recruiting A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL) · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06873854Phase 2 · not yet recruiting A Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06093438Phase 1/Phase 2 · recruiting Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer · 335 trials list this drug (191 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06851247Phase 2 · recruiting GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma. · 335 trials list this drug (191 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04785196Phase 1/Phase 2 · recruiting APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm,Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04804696Phase 2 · terminated Toripalimab with Paclitaxel and Cisplatin As Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma · 335 trials list this drug (191 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05188664Phase 1/Phase 2 · completed Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06642545Phase 2 · recruiting Efficacy and Safety Study of Disitamab Vedotin + RC148 vs. Albumin-Paclitaxone ± Toripalimab in HR-/HER2-low Breast Cancer · 335 trials list this drug (191 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05021328Phase 1 · completed Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC · 335 trials list this drug (191 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06028672NA · recruiting Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6 · 335 trials list this drug (191 active) | — | — | Gestational Trophoblastic Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06333561recruiting HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma · 335 trials list this drug (191 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05033392Phase 2 · recruiting PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer · 335 trials list this drug (191 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06038396Phase 1/Phase 2 · recruiting A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05031494Phase 2 · completed A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers · 335 trials list this drug (191 active) | — | — | Melanoma,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06020755Phase 2 · recruiting Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7 · 335 trials list this drug (191 active) | — | — | Gestational Trophoblastic Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05615974Phase 1/Phase 2 · recruiting A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors · 335 trials list this drug (191 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05215665NA · unknown GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma · 335 trials list this drug (191 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03623776Phase 2 · withdrawn Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC. · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06717464Phase 2 · active not recruiting Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer · 335 trials list this drug (191 active) | — | — | Malignant Gallbladder Neoplasm,Distal Cholangiocarcinoma,Hilar Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05060471Phase 2 · completed PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients · 335 trials list this drug (191 active) | — | — | Anal Squamous Cell Carcinoma,Malignant Anal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06705127Phase 2 · recruiting Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC. · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06117566Phase 1/Phase 2 · recruiting A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors · 335 trials list this drug (191 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06269211Phase 2 · recruiting Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression · 335 trials list this drug (191 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06692491Phase 2 · not yet recruiting Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS · 335 trials list this drug (191 active) | — | — | Rare Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06690697Phase 2 · recruiting Combination of Toripalimab and JS004 Therapy for ccRCC · 335 trials list this drug (191 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06647563Phase 3 · not yet recruiting Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT) · 335 trials list this drug (191 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06648200Phase 2 · not yet recruiting Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06612632Phase 1/Phase 2 · recruiting Immunotherapy Rechallenge in Patients with Solid Tumors in Clinical Trials · 335 trials list this drug (191 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05963490Phase 2 · recruiting Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06079112Phase 1/Phase 2 · recruiting 9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer · 335 trials list this drug (191 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06389526Phase 1 · not yet recruiting A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06588335Phase 2 · not yet recruiting BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma · 335 trials list this drug (191 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592326Phase 3 · recruiting 9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer · 335 trials list this drug (191 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06105008Phase 2 · withdrawn Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer · 335 trials list this drug (191 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06548763Phase 2 · not yet recruiting Oral Topotecan With Toripalimab for Patients With Endometrial Cancer · 335 trials list this drug (191 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04144608Phase 2 · completed Toripalimab Combined With Double Platinum-based Chemotherapy for Initially Unresectable NSCLC · 335 trials list this drug (191 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06547203Phase 2 · recruiting Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study · 335 trials list this drug (191 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06387628Phase 2 · recruiting LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer · 335 trials list this drug (191 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06492629Phase 2 · unknown Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma · 335 trials list this drug (191 active) | — | — | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |